Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

C+D scoops awards for investigations and pharmacy writing

Two members of C+D were recognised for championing the sector at the annual Avicenna awards for pharmacy journalism.

C+D’s deputy news editor Annabelle Collins was crowned Pharmacy Writer of the Year, with judges name-checking both her Brexit coverage and the letter she drafted about the funding pharmacy cuts for an MP to read out in parliament.

Deputy editor Lilian Anekwe picked up the Best Investigation award, for compiling more than 100 Freedom of Information requests to exclusively reveal how many clinical commissioning groups are scrapping repeat dispensing schemes to save cash.

C+D was the only title to scoop two trophies at the Avicenna Media Awards, held at the Ismali Centre in London last Friday (January 27).

This year’s awards – which annually hunts the very best writers in the pharmacy trade press – is the first of a series of events to be held this year to mark Avicenna’s 25th anniversary.

What was your favourite C+D story from last year?

Related Content

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD008568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel